Grey Innovation is one of nine Australian businesses and research organisations to be awarded grant funding under the Global Innovation Linkages program. This program aims to strengthen global collaboration, build Australia’s research capacity, increase the commercialisation of research outcomes, and boost Australia’s innovation and international competitiveness.
Under this program, Grey Innovation in collaboration with Charles Sturt University, the University of Rostock, and the DZNE (German Centre for Neurodegenerative Diseases), are furthering the development of a wearable system for the monitoring of physiological and behavioural parameters associated with Alzheimer’s disease. The wearable system will support people who suffer from Alzheimer’s disease and their care givers by providing remote monitoring of disease progression, allowing the efficacy of treatments to be objectively measured and informing more effective management strategies and personalised care.
Worldwide there are more than 46 million people who suffer from dementia, a figure which is predicted to rise to 135 million by 2050. The most common form of dementia is Alzheimer’s disease, affecting more than 70% of people with dementia. Globally, the total cost of dementia is estimated at more than US$800 billion.
The Global Innovation Linkages program brings together a consortium of leading global players from Australia and Germany to address this global industry challenge. For the full announcement on the Global Innovation Linkages program, please click here.